An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of an approved medication on the
symptoms of seasonal allergic rhinitis (a seasonal variety of inflammation of the mucous
membrane of the nose) in patients who are experiencing symptoms of seasonal allergic rhinitis
and asthma.